The 2020 Medical Specialties Matching Program (MSMP), a division of the National Resident Matching Program (NRMP), matched a record number of applicants to subspecialty training programs for positions beginning in 2021, the NRMP reported.
"Specifically, the 2020 MSMP included 6847 applicants submitting certified rank order lists (an 8.9% increase), 2042 programs submitting certified rank order lists (a 4.3% increase), 5734 positions (a 2.8% increase), and 5208 positions filled (a 6.1% increase)," according to a news release.
The MSMP now includes 14 internal medicine subspecialties and four sub-subspecialties. The MSMP offered 5734 positions this year, and 5208 (90.8%) were successfully filled. That represents an increase of almost 3 percentage points compared with last year's results.
Among those subspecialties that offered 30 positions or more, the most competitive were allergy and immunology, cardiovascular disease, clinical cardiac electrophysiology, gastroenterology, hematology and oncology, and pulmonary/critical care. Each of those filled at least 95% of available slots. More than half of the positions were filled by US MDs.
By contrast, the least competitive subspecialities were geriatric medicine and nephrology. Programs in these two fields filled less than 75% of positions offered. Less than 45% were filled by US MDs.
More than 76% of the 6847 applicants who submitted rank order lists (5208) matched into residency programs.
The number of US MDs in this category increased nearly 7% over last year, with a total of 2935. The number of DO graduates increased as well, with a total of 855, which was 9.6% more than the previous year.
More US citizens who graduated from international medical schools matched this year as well; 1087 placed into subspecialty residency, a 9% increase compared with last year.
Follow Medscape on Facebook, Twitter, Instagram, and YouTube.
Medscape Medical News © 2020
Send news tips to news@medscape.net.
Cite this: New Residency Matching Sets Record, Says NRMP - Medscape - Dec 04, 2020.
Comments